| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10064807 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2005 | 8 Pages |
Abstract
LIF was immunohistochemically demonstrated in normal, hyperplastic and malignant endometrial tissue, suggesting a widespread but complex role for LIF in hyperplastic and malignant endometrial growth regulation. AH I-III also expressed LIF with statistically higher immunostaining than adenocarcinoma. Since AH III can be considered as a precursor of endometrial cancer, LIF could be a marker of cell transformation.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ioannis Mylonas, Josef Makovitzky, Naim Shabani, Dagmar-Ulrike Richter, Christina Kuhn, Udo Jeschke, Volker Briese, Klaus Friese,